| Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ... The Lancet 382 (9896), 951-962, 2013 | 3079 | 2013 |
| Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis S Leucht, C Corves, D Arbter, RR Engel, C Li, JM Davis The Lancet 373 (9657), 31-41, 2009 | 2630 | 2009 |
| Norepinephrine in depressive reactions: A review WE Bunney, JM Davis Archives of General Psychiatry 13 (6), 483-494, 1965 | 1655 | 1965 |
| A meta-analysis of the efficacy of second-generation antipsychotics JM Davis, N Chen, ID Glick Archives of general psychiatry 60 (6), 553-564, 2003 | 1592 | 2003 |
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study A Guidotti, J Auta, JM Davis, VDG Gerevini, Y Dwivedi, DR Grayson, ... Archives of general psychiatry 57 (11), 1061-1069, 2000 | 1443 | 2000 |
| A cholinergic-adrenergic hypothesis of mania and depression DS Janowsky, JM Davis, MK El-Yousef, HJ Sekerke The Lancet 300 (7778), 632-635, 1972 | 1418 | 1972 |
| Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study JR Hibbeln, JM Davis, C Steer, P Emmett, I Rogers, C Williams, J Golding The Lancet 369 (9561), 578-585, 2007 | 1409 | 2007 |
| Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ... The Lancet 394 (10202), 939-951, 2019 | 1396 | 2019 |
| Efficacy of divalproex vs lithium and placebo in the treatment of mania CL Bowden, AM Brugger, AC Swann, JR Calabrese, PG Janicak, F Petty, ... Jama 271 (12), 918-924, 1994 | 1321 | 1994 |
| Physical health monitoring of patients with schizophrenia SR Marder, SM Essock, AL Miller, RW Buchanan, DE Casey, JM Davis, ... American Journal of Psychiatry 161 (8), 1334-1349, 2004 | 1177 | 2004 |
| Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis S Leucht, M Tardy, K Komossa, S Heres, W Kissling, G Salanti, JM Davis The Lancet 379 (9831), 2063-2071, 2012 | 1140 | 2012 |
| Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. MP Freeman, JR Hibbeln, KL Wisner, JM Davis, D Mischoulon, M Peet, ... Journal of Clinical psychiatry 67 (12), 1954, 2006 | 1062 | 2006 |
| Diagnosis and drug treatment of psychiatric disorders DF Klein, JM Davis Psychopharm Review 4 (6), 24, 1969 | 1034 | 1969 |
| The Altman self-rating mania scale EG Altman, D Hedeker, JL Peterson, JM Davis Biological psychiatry 42 (10), 948-955, 1997 | 1000 | 1997 |
| The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials SR Marder, JM Davis, G Chouinard J Clin Psychiatry 58 (12), 538-546, 1997 | 958 | 1997 |
| A decrease of reelin expression as a putative vulnerability factor in schizophrenia F Impagnatiello, AR Guidotti, C Pesold, Y Dwivedi, H Caruncho, MG Pisu, ... Proceedings of the National Academy of Sciences 95 (26), 15718-15723, 1998 | 931 | 1998 |
| Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis C Rummel-Kluge, K Komossa, S Schwarz, H Hunger, F Schmid, ... Schizophrenia research 123 (2-3), 225-233, 2010 | 886 | 2010 |
| Bulimia: Its incidence and clinical importance in patients with anorexia nervosa RC Casper, ED Eckert, KA Halmi, SC Goldberg, JM Davis Archives of General Psychiatry 37 (9), 1030-1035, 1980 | 842 | 1980 |
| Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine V Uzunova, Y Sheline, JM Davis, A Rasmusson, DP Uzunov, E Costa, ... Proceedings of the National Academy of Sciences 95 (6), 3239-3244, 1998 | 792 | 1998 |
| Moving the participation agenda forward M Hill, J Davis, A Prout, K Tisdall Children & society 18 (2), 77-96, 2004 | 785 | 2004 |
Stefan LeuchtProf. Dr. med., Klinik für Psychiatrie und Psychotherapie der TU-MünchenVerified email at lrz.tum.de
